Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 11 holding rows worth $120,707,596.

Accession
0000950123-25-002355
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 11 entries on the cover page, a total value of $120,707,596 stated on the cover page (in dollars after the unit check, H1), rows summing to $120,707,597 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BICARA THERAPEUTICS INC055477103COM2,204,650$38,405,003dollars as filed
NUVATION BIO INC COM CL A67080N101Stock13,072,340$34,772,424dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK1,975,203$23,919,708dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK1,184,636$7,794,905dollars as filed
ALUMIS INC022307102COM653,223$5,134,333dollars as filed
IKENA ONCOLOGY INC45175G108COM2,249,123$3,688,562dollars as filed
ENGENE HOLDINGS INC29286M105COM526,357$3,500,274dollars as filed
IMMUNIC INC4525EP101COM1,788,160$1,788,160dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$1,375,313dollars as filed
ENGENE HOLDINGS INC29286M113W EXP 10/31/2028321,502$271,123dollars as filed
SYROS PHARMACEUTICALS INC87184Q206COM NEW251,270$57,792dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-002355this filing2025-02-14acceptance time not in the bulk data set
13F-HR/A 0000950123-25-005507 added2025-05-15acceptance time not in the bulk data set